ANEMOCYTE

Serial Number 79188650
Registration 5215720
706

Registration Progress

Application Filed
Sep 11, 2015
Under Examination
Approved for Publication
Mar 21, 2017
Published for Opposition
Mar 21, 2017
Registered
Jun 6, 2017

Trademark Image

ANEMOCYTE

Basic Information

Serial Number
79188650
Registration Number
5215720
Filing Date
September 11, 2015
Registration Date
June 6, 2017
Published for Opposition
March 21, 2017
Drawing Code
4

Status Summary

Current Status
Active
Status Code
706
Status Date
Feb 28, 2025
Registration
Registered
Classes
005 010 042

Rights Holder

ANEMOCYTE S.R.L.

03
Address
Via Roberto Lepetit, 34
GERENZANO (VA) I-21040
IT

Ownership History

ARETA INTERNATIONAL S.R.L.

Original Applicant
03
IT

ARETA INTERNATIONAL S.R.L.

Owner at Publication
03
IT

ANEMOCYTE S.R.L.

Original Registrant
03
GERENZANO (VA) IT

Legal Representation

Attorney
Brian A. Tollefson

Application History

50 events
Date Code Type Description Documents
Jul 3, 2025 RNWL P INTERNATIONAL REGISTRATION RENEWED Loading...
Feb 28, 2025 71AG O REGISTERED-SEC.71 ACCEPTED Loading...
Feb 28, 2025 NA71 E NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Loading...
Nov 15, 2024 INNA R INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Loading...
Oct 25, 2024 INPR P PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Loading...
Aug 21, 2024 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Loading...
Feb 24, 2024 PR71 O POST REGISTRATION ACTION MAILED - SEC.71 Loading...
Feb 12, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jun 5, 2023 ES71 I TEAS SECTION 71 RECEIVED Loading...
Oct 24, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 24, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 24, 2022 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Oct 24, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Oct 24, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 24, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 24, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 6, 2022 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Apr 9, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Feb 22, 2018 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Oct 28, 2017 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Sep 14, 2017 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Sep 14, 2017 FIMP P FINAL DISPOSITION PROCESSED Loading...
Sep 6, 2017 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jun 6, 2017 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 21, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 21, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 17, 2017 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Mar 1, 2017 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Mar 1, 2017 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Mar 1, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 14, 2017 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Feb 1, 2017 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 1, 2017 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 1, 2017 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 1, 2017 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 1, 2017 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 1, 2017 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 1, 2017 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 1, 2017 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 1, 2017 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 8, 2017 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jan 8, 2017 GNFR O FINAL REFUSAL E-MAILED Loading...
Jan 8, 2017 CNFR R FINAL REFUSAL WRITTEN Loading...
Dec 22, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 22, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 7, 2016 ALIE A ASSIGNED TO LIE Loading...
Nov 16, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 11, 2016 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 11, 2016 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 29, 2016 RFNT P REFUSAL PROCESSED BY IB Loading...

Detailed Classifications

Class 005
Pharmaceutical and veterinary preparations, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for use in human [ and veterinary ] medicine; chemical preparations for pharmaceutical or medical purposes, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, syringes, infusion bags, vials and pharmaceutical preparations for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; biological preparations for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; biological preparations for medical and pharmaceutical use for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; chemical preparations for pharmaceutical purposes, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; preparations for diagnostics for medical purposes; drugs, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for medical and veterinary purposes; medicines for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; organic products for medical use, namely, natural biomaterials for cell delivery or for augmentation of tissues for medical purposes; biological reagents for medical use; medicinal products based on cells and genes, namely, somatic cells, genetically modified cells, viral vectors, nucleic acids and engineered tissues; products for somatic cell therapy, namely, adult stem cells, t-cells, b-cells, nk cells, dendritic cells, monocytes, macrophages, adipocytes, keratinocytes, erythrocytes, platelets, products for gene therapy, namely, genetically modified cells, viral vectors, nucleic acids; tissue engineered products, namely, cells and tissues that have been subjected to extensive manipulation and are used with the aim to repair, replace or restore a lost or impaired tissue or function; products for regenerative medicine, namely, cells and tissues that have been subjected to extensive manipulation and are used with the aim to repair, replace, restore or promote the repair, replacement or regeneration of a lost or impaired tissue or function; products for personalized medicine made of autologous cells or proteins or nucleid acids derived from individual genomic sequences; preparations made up of cells for medical or clinical use; preparations made up of nucleic acids, namely, nucleic acid sequences and chemical reagents for medical purposes; preparations made up of tissues, namely, biological tissue cultures for medical purposes; vaccines; recombinant proteins supplements; therapeutic kits consisting of therapeutic antibodies, buffers, and reagents for use in disease treatment and therapy
Class 010
[ Surgical apparatus and instruments for medical, dental and veterinary use; medical devices for the introduction of pharmaceutical preparations in the human body, in particular syringes and catheters; medical equipment, namely, centrifuges or other separation devices for the isolation of cell sub-populations from tissues and biopsies; surgical apparatus and instruments for medical and veterinary purpose; electrical medical instruments for use in electroporation of cells and tissues for gene transfer purposes, both in vivo and ex-vivo; electronic medical instruments for use in imaging for diagnostic purposes or for monitoring of vital signs of patients ]
Class 042
Services of laboratory analysis and industrial research in the medical and pharmaceutical fields; research and development in the pharmaceutical and biotechnology fields; research and development in the field of micro-organisms and cells; research and development in biochemistry; scientific research and development in biology; research and development in the field of diagnostic preparations; services of medical laboratories; Providing medical and scientific research information and data on developments in the medical and veterinary fields; scientific and technological services, namely, scientific research in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; consultancy to ensure compliance with quality standards and the design and validation of manufacturing processes in the scientific field and medical technology fields

Classification

International Classes
005 010 042